249 related articles for article (PubMed ID: 12236169)
1. Nitric oxide regulation of penile erection: biology and therapeutic implications.
Burnett AL
J Androl; 2002; 23(5):S20-6. PubMed ID: 12236169
[No Abstract] [Full Text] [Related]
2. Phosphodiesterase type 5 inhibitors: a biochemical and clinical correlation survey.
Kim NN
Int J Impot Res; 2003 Oct; 15 Suppl 5():S13-9. PubMed ID: 14551572
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase-5 inhibition: the molecular biology of erectile function and dysfunction.
Francis SH; Corbin JD
Urol Clin North Am; 2005 Nov; 32(4):419-29, vi. PubMed ID: 16291034
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of action of PDE5 inhibition in erectile dysfunction.
Corbin JD
Int J Impot Res; 2004 Jun; 16 Suppl 1():S4-7. PubMed ID: 15224127
[TBL] [Abstract][Full Text] [Related]
5. Phosphodiesterase 5 mechanisms and therapeutic applications.
Burnett AL
Am J Cardiol; 2005 Dec; 96(12B):29M-31M. PubMed ID: 16387563
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase type 5 inhibitors for erectile dysfunction.
Carson CC; Lue TF
BJU Int; 2005 Aug; 96(3):257-80. PubMed ID: 16042713
[TBL] [Abstract][Full Text] [Related]
7. [7 years PDE-5 inhibitor for therapy of erection disorders].
Krankenpfl J; 2005; 43(7-10):267. PubMed ID: 16518894
[No Abstract] [Full Text] [Related]
8. This paper continues Professor Adaikan's distinguished involvement in classical pharmacologic research of erectile physiology.
Pickard R
Eur Urol; 2007 Jul; 52(1):259-60. PubMed ID: 17616089
[No Abstract] [Full Text] [Related]
9. [Erectile dysfunction and phosphodiesterase type 5 inhibitors].
Roumeguère T; Sternon J; Schulman CC
Rev Med Brux; 2003 Jun; 24(3):169-75. PubMed ID: 12891884
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide and penile erectile function.
Toda N; Ayajiki K; Okamura T
Pharmacol Ther; 2005 May; 106(2):233-66. PubMed ID: 15866322
[TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase inhibitors for the treatment of erectile dysfunction.
Küthe A; Montorsi F; Andersson KE; Stief CG
Curr Opin Investig Drugs; 2002 Oct; 3(10):1489-95. PubMed ID: 12431025
[TBL] [Abstract][Full Text] [Related]
12. [Phosphodiesterase-5 inhibitor with broad temporal effectiveness window].
MMW Fortschr Med; 2004 Apr; 146(16):62. PubMed ID: 15222506
[No Abstract] [Full Text] [Related]
13. [Levitra (vardenafil)--a new PDE 5 inhibitor for the treatment of erectile dysfunction].
Katsarov M
Akush Ginekol (Sofiia); 2004; 43 Suppl 1():31-2. PubMed ID: 15323315
[No Abstract] [Full Text] [Related]
14. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide-cyclic GMP pathway with some emphasis on cavernosal contractility.
Ghalayini IF
Int J Impot Res; 2004 Dec; 16(6):459-69. PubMed ID: 15229623
[TBL] [Abstract][Full Text] [Related]
16. [New PDE-5 inhibitor for treatment of impotence. 9 out of 10 have erections again].
MMW Fortschr Med; 2003 Jun; 145(26):59. PubMed ID: 12916343
[No Abstract] [Full Text] [Related]
17. Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy.
Nehra A; Grantmyre J; Nadel A; Thibonnier M; Brock G
J Urol; 2005 Jun; 173(6):2067-71. PubMed ID: 15879836
[TBL] [Abstract][Full Text] [Related]
18. PDE5 inhibitors: looking beyond ED.
Jackson G
Int J Clin Pract; 2003 Apr; 57(3):159-60. PubMed ID: 12723713
[No Abstract] [Full Text] [Related]
19. Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism.
Burnett AL; Bivalacqua TJ; Champion HC; Musicki B
Urology; 2006 May; 67(5):1043-8. PubMed ID: 16698365
[TBL] [Abstract][Full Text] [Related]
20. In vivo and in vitro response of corpus cavernosum to phosphodiesterase-5 inhibition in the hypercholesterolaemic rabbit.
Lau DH; Thompson CS; Morgan RJ; Mumtaz FH; Mikhailidis DP
BJU Int; 2005 Dec; 96(9):1424. PubMed ID: 16287475
[No Abstract] [Full Text] [Related]
[Next] [New Search]
